Trademarkia Logo

Canada

C$
GEOMETRICAL FIGURE DESIGN
REGISTERED

on 3 Aug 2022

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2005192 filed on 5th Nov 2019

Registration Number

TMA1136325 registered on 3rd Aug 2022

Registration expiry Date

5th Nov 2029

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

GEOMETRICAL FIGURE DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Vienna Information


27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 22

Monograms formed of intertwined, overlapping or otherwise combined lettersMonogrammes formés par des lettres enlacées, se chevauchant ou combinées autrement

27 . 7 . 1

Numerals presenting a special form of writingChiffres présentant un graphisme spécial

27 . 7 . 11

Numerals juxtaposed or joined to a letter or a figurative elementChiffres juxtaposés ou accolés à une lettre ou à un élément figuratif

29 . 1 . 4

BlueBleu

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; antiinflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, antibiotics, systemic and topical antifungals.


Classification kind code

11

Mark Details


Serial Number

2005192

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 18th Feb 2022
Agent Changed
Submitted for opposition 22
on 7th May 2021
Search Recorded
Submitted for opposition 20
on 7th May 2021
Examiner's First Report
Submitted for opposition 223
on 7th May 2021
Total Provisional Refusal
Submitted for opposition 256
on 9th Nov 2020
Notification of Possible Opposition Sent
Submitted for opposition 257
on 9th Jan 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 8th Jan 2020
Formalized
Submitted for opposition 1
on 8th Jan 2020
Created
Submitted for opposition 228
on 5th Nov 2019
International Registration
Submitted for opposition 30
on 5th Nov 2019
Filed